Eddington N D, Cox D S, Roberts R R, Stables J P, Powell C B, Scott K R
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, Baltimore, MD 21201-4403, USA.
Curr Med Chem. 2000 Apr;7(4):417-36. doi: 10.2174/0929867003375092.
Enaminones, enamines of ss-dicarbonyl compounds, have been know for many years. In our initial account (Current Med. Chem. 1994, 1, 159-175), we reported on the anticonvulsant activity of a series of enaminones, notably methyl 4-[(p-chlorophenyl)amino]-6-methyl-2-oxo-cyclohex-3-en- 1-oate, 9a (R=CH3, R1=4-Cl), which, in animal tests, compared favorably to phenytoin and carbamazepine. Since that time, further research in our laboratory and other laboratories have expanded the therapeutic potential of these compounds. In addition to new anticonvulsant derivatives, we have uncovered a novel brain transport mechanism for the enaminones and developed a preliminary regression model for further synthetic direction. These topics will each be presented and elaborated.
烯胺酮,即β-二羰基化合物的烯胺,已被人们熟知多年。在我们最初的报道(《当代药物化学》,1994年,第1卷,第159 - 175页)中,我们报道了一系列烯胺酮的抗惊厥活性,特别是4-[(对氯苯基)氨基]-6-甲基-2-氧代-环己-3-烯-1-酸甲酯,9a(R = CH₃,R₁ = 4-Cl),在动物试验中,其效果优于苯妥英和卡马西平。从那时起,我们实验室和其他实验室的进一步研究扩展了这些化合物的治疗潜力。除了新的抗惊厥衍生物外,我们还发现了烯胺酮一种新的脑转运机制,并为进一步的合成方向建立了初步的回归模型。这些主题将分别进行介绍和阐述。